Please ensure Javascript is enabled for purposes of website accessibility

Wall Street’s Best Investments 819

Congratulations to our Top Picks for 2019! For the first half of the year, the Dow Jones Industrial Average was up 11.8%; the S&P 500 gained 14.3%, and the NASDAQ has returned 16.1%. Our Top Five picks averaged gains of 68.02%!

Wall Street’s Best Investments 819

[premium_html_toc post_id="181269"]

image-blank.png

Congrats to the Top Picks 2019, Mid-Year

Congratulations to our Top Picks for 2019! For the first half of the year, the Dow Jones Industrial Average was up 11.8%; the S&P 500 gained 14.3%, and the NASDAQ has returned 16.1%. But, as you can see from the table below, that’s nothin’, compared to our Top Picks!

wsbi819-toppicks

Our Top Five picks averaged gains of 68.02%!

Winning the gold is Nate Pile, editor of Nate’s Notes, who chose Catasys, Inc. (CATS), for a fantastic return of 88.5%. Here’s what Nate had to say about Catasys last January: “For more speculative investors, one of my favorite stocks is Catasys. This up -and-coming company has developed a proprietary data analysis platform that it combines with predictive modeling techniques to identify individuals in a healthcare plan who suffer from chronic conditions.

Catasys is one of the companies that is enjoying “first to market” status. And, provided it can continue to deliver the sorts of results it has been delivering thus far, the company ought to be able to stay ahead of the competition for the foreseeable future. CATS is a strong buy under $10 and a buy under $15.”

Bringing home the silver is William Velmer of S.A. Advisory. His pick was Arrowhead Pharmaceuticals, Inc. (ARWR), which returned 81.0% to investors. In his write-up, William noted, “ARWR therapies trigger RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. Recently, AMGN & JNJ invested heavily with the potential of over $4 billion in payments during milestones being reached. There are 100’s upon 100’s of diseases that could be cured using ARWR’s methods of FC (functional cure) that may change the world of medicine concerning how to cure diseases. We believe because of all the milestones that will be met during 2019, that the share price could easily double or triple.”

And grabbing the bronze medal is Jeffrey Hirsch, editor of The Stock Trader’s Almanac, with his recommendation of Global Brass & Copper (BRSS). Jeffrey said this, “Copper has a tendency to make a major seasonal bottom in December and then a tendency to post major seasonal peaks in April or May. One way we like to gain exposure to copper and its seasonally strong period is through the highly correlated stocks of companies that mine and produce copper.

Global Brass and Copper is our favorite small cap stock that is highly correlated to copper. It primarily operates in the U.S. as a converter, fabricator and processor of copper and brass products. Global Brass is not a mining company; it is essentially a recycler that produces sheet, strip, foil, rod, tube and similar products from processed scrap, used copper cathodes and other refined metal sources. With copper appearing to set its perennial seasonal low in December and Global Brass and Copper’s solid business, the company is well-positioned to drive growth organically as well as through acquisitions. The stock is recommended for risk-oriented investors.”

Coming in fourth is Jim Woods of Bullseye Trader, with his choice of Match Group, Inc. (MTCH). In his recommendation, Jim noted, “Match Group, the online dating site company, operates high-profile dating sites such as its namesake Match, Tinder, Plenty Of Fish, Meetic, Ok Cupid, Pairs, Twoo, and OurTime. The result of MTCH’s operations have been EPS growth (both current and over the past several years) that’s in the top 3% of all publicly-traded companies.

On the share price front, MTCH’s approximate 30% gain in 2018 put it in the top 10% of all publicly-traded companies. And because stocks that show positive momentum on strong earnings tend to continue showing positive momentum, I think MTCH will continue riding higher in 2019.”

And in fifth place, we have a tie. Both Joseph Parnes, editor of Shortex Market Letter and Gene Inger, editor of The Inger Letter, recommended Advanced Micro Devices, Inc. (AMD)

Here are Joseph’s comments: “Chipmaker Advanced Micro Devices, Inc. (AMD) has benefited from its graphic processing units (GPUs) and has made significant inroads in its cloud data processors for Amazon’s Web Services (AWS) and Microsoft’s Azure. AMD is posing a significant challenge to Intel (INTC) with its data center’s chips, due to AMD’s single socket boards and lower prices, which is a plus in the current memory market environment. Q4-18 earnings estimate could increase substantially with the introduction of new products within its Computing and Graphics segment and its Ryzen CPUs.

“Technical Picture: AMD is in a correction /retraction mode, where stock price ebbed at (32-34) area, as the daily On-Balance-Value (OBV) is in declining retraction mode. Sellers are showing their shift toward a downside pattern, and should expect a long consolidation pattern in the current area. Exhaustion of selling makes room for MACD oscillator: (31-27) to (27-25) to (25-22). Plunging (23-19). Reversal met resistance at 50-DMA (23-24). Sinking through 200-DMA: (23-20) to (20-18) to (18-16). Reversal to challenge its primary resistance at (18-19) and secondary resistance at (22-23).”

And Gene added: “AMD is the only ‘semi’ that develops both high-performance CPU and GPU products, a competitive advantage as the company introduces multiple products outperforming competitors. What it is introducing now (I saw at IFA and now CES) is part of next generation computing to help define AI, AR, and even run algorithms for autonomous vehicles down the road (pun intended). 2019 will be a transition year, with alternating swings that, regardless of ‘trade deals’ or lower Index prices, will launch new computing, graphics and even infrared defense, medical and vehicular products.”

A big congratulations for a job well done to all our contributors!


To read the rest of this month’s issue, download the PDF.


THE NEXT Wall Street’s Best Investments will be published August 7, 2019
Neither Cabot Wealth Network nor our employees are compensated by the companies we recommend. Sources of information are believed to be reliable, but are in no way guaranteed to be complete or without error. Recommendations, opinions or suggestions are given with the understanding that subscribers acting on the information assume all risks. © Cabot Wealth Network. Copying and/or electronic transmission of this report is a violation of U.S. copyright law. For the protection of our subscribers, if copyright laws are violated, the subscription will be terminated. To subscribe or for information on our privacy policy, call 978-745-5532, visit www.cabotwealth.com or write to support@cabotwealth.com.